Patent Yard Sign in
Canadian application, no grantCanada

Method for identification of tumor targeting enzymes

CA 2468170 A1 · Owner: Tsukuda, Takuo · Inventors: Okabe, Hisafumi; Shimma, Nobuo; Tsukuda, Takuo

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention relates to a method for identification of enzymes that are preferentially expressed in certain tumor tissue as compared with rapidly growing normal cells or tissue, use of said enzymes for the compound design to generate an active anticancer substance selectively in tumor tissue compounds , designed based on said enzymes their pharmaceutically acceptable salts as well as pharmaceutical composition thereof.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed November 18, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 18, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 18, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 18, 2002
GrantedNo grant recorded
Term endedNovember 18, 2022
Patent numberCA 2468170 A1
Classification (IPC)C07D491/22 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedNov 18, 2002Term endedNov 18, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.